Truth: youll also lose less weight
GHK-Cu creates a healthier scalp environment: reducing local DHT, increasing blood supply through VEGF, calming inflammation, and remodeling the extracellular matrix around follicles

Food and Drug Administration approved Wegovy (semaglutide) injection (2.4 mg once weekly) for chronic weight management in adults with obesity or overweight with at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol), for use in addition to a reduced calorie diet and increased physical activity. The drug is indicated for chronic weight management in patients with a body mass index (BMI) of 27 kg/m2 or greater who have at least one weight-related ailment or in patients with a BMI of 30 kg/m2 or greater. Semaglutide and Its Impact on Weight Loss Several studies have been published looking at the effects of Semaglutide injections on weight loss: Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity This study which was published in 2022 looked at the effects of Semaglutide weekly 1.7-mg or 2.4-mg subcutaneous injections for 3 to 6 months

The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care
This weight loss medication also slows down the rate at which the stomach empties, improving blood sugar control
The American Academy of Pediatrics says it doesnt have any official policy on breastfeeding while taking semaglutide